• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Exclusive-India likely to block Chinese investment in insurance giant LIC’s IPO -sources

September 23, 2021 by David Barret Leave a Comment

September 23, 2021

By Aftab Ahmed, Manoj Kumar and Nupur Anand

NEW DELHI (Reuters) -New Delhi wants to block Chinese investors from buying shares in Indian insurance giant Life Insurance Corp (LIC) which is due to go public, four senior government officials and a banker told Reuters, underscoring tensions between the two nations.

State-owned LIC is considered a strategic asset, commanding more than 60% of India’s life insurance market with assets of more than $500 billion. While the government is planning to allow foreign investors to participate in what is likely to be the country’s biggest-ever IPO worth a potential $12.2 billion, it is leery of Chinese ownership, the sources said.

Political tensions between the countries rocketed last year after their soldiers clashed on the disputed Himalayan border and since then, India has sought to limit Chinese investment in sensitive companies and sectors, banned a raft of Chinese mobile apps and subjected imports of Chinese goods to extra scrutiny.

“With China after the border clashes it cannot be business as usual. The trust deficit has significantly widen(ed),” said one of the government officials, adding that Chinese investment in companies like LIC could pose risks.

The sources declined to be identified as discussions on how Chinese investment might be blocked are ongoing and as no final decisions have been made.

India’s finance ministry and LIC did not respond to Reuters emailed requests for comment.

“It is hoped that India will provide an open, fair, just and non-discriminatory investment and business environment for Chinese companies, which is also in India’s own interests,” China’s foreign ministry said, adding economic and trade cooperation between China and India was mutually beneficial.

Aiming to solve budget constraints, Prime Minister Narendra Modi’s administration is hoping to raise 900 billion rupees through selling 5% to 10% of LIC this financial year which ends in March. The government has yet to decide on whether it will sell one tranche of shares seeking to raise the full amount or choose to seek the funds in two tranches, sources have said.

Under current law, no overseas investors can invest in LIC but the government is considering allowing foreign institutional investors to buy up to 20% of LIC’s offering.

Options to prevent Chinese investment in LIC include amending the current law on foreign direct investment with a clause that relates to LIC or creating a new law specific to LIC, two of the government officials said.

They added that the government was conscious of the difficulty in checking on Chinese investments that could come indirectly and would attempt to craft a policy that would protect India’s security but not deter overseas investors.

A third option being explored is barring Chinese investors from becoming cornerstone investors in the IPO, said one government official and the banker, although that would not prevent Chinese investors from buying shares in the secondary market.

Ten investment banks including Goldman Sachs, Citigroup and SBI Capital Market have been chosen to handle the offering.

($1 = 73.8200 Indian rupees)

(Reporting by Aftab Ahmed and Manoj Kumar in New Delhi, Nupur Anand in Mumbai; Additional reporting by Beijing Newsroom; Editing by Sanjeev Miglani and Edwina Gibbs)

Source Link Exclusive-India likely to block Chinese investment in insurance giant LIC’s IPO -sources

David Barret
David Barret

Related posts:

  1. IFRC urges urgent global humanitarian support for Afghanistan
  2. Global reinsurance rates to keep rising next year – Moody’s
  3. Pro-Putin party heads for Russian election win after Navalny clampdown
  4. Italy reports 26 coronavirus deaths on Sunday, 3,838 new cases

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • Inhaling “Laughing Gas” Could Treat Severe Depression, Live Seven-Arm Octopus Spotted In The Deep Sea, And Much More This Week
  • People Are Surprised To Learn That The Closest Planet To Neptune Turns Out To Be Mercury
  • The Age-Old “Grandmother Rule” Of Washing Is Backed By Science
  • How Hero Of Alexandria Used Ancient Science To Make “Magical Acts Of The Gods” 2,000 Years Ago
  • This 120-Million-Year-Old Bird Choked To Death On Over 800 Stones. Why? Nobody Knows
  • Radiation Fog: A 643-Kilometer Belt Of Mist Lingers Over California’s Central Valley
  • New Images Of Comet 3I/ATLAS From 4 Different Missions Reveal A Peculiar Little World
  • Neanderthals Used Reindeer Bones To Skin Animals And Make Leather Clothes
  • Why Do Power Lines Have Those Big Colorful Balls On Them?
  • Rare Peek Inside An Egg Sac Reveals An Adorable Developing Leopard Shark
  • What Is A Superhabitable Planet And Have We Found Any?
  • The Moon Will Travel Across The Sky With A Friend On Sunday. Here’s What To Know
  • How Fast Does Sound Travel Across The Worlds Of The Solar System?
  • A Wonky-Necked Giraffe In California Lived To 21 Against The Odds
  • Seal Finger: What Is This Horrible Infection That Makes Your Hand Swell Like A Balloon?
  • “They Usually Aren’t Second Tier”: When Wolves Adopt Pups From Rival Packs
  • The Road To New Physics Beyond Our Knowledge Might Pass Through Neutrinos
  • Flu Season Is Revving Up – What Are The Symptoms To Look Out For?
  • Asteroid Bennu Was Missing Just One Ingredient Needed To Kickstart Life – We just Found It
  • Rare Core Samples Provide “Once In A Lifetime” Opportunity To Study The Giant Line That Slices Through Scotland
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version